Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert C Rees

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Cancer Immunology, Immunotherapy : CII|January 13, 2006
The identification of human tumour antigens: Current status and future developmentsAmanda K Miles, Balwir Matharoo-Ball, Geng Li, et al.
Methods in Molecular Medicine|May 3, 2003
Phenotypic and functional differences of dendritic cells generated under different in vitro conditionsStephanie E B McArdle, Selman A Ali, Geng Li, et al.
Journal of Immunological Methods|August 23, 2002
Optimised SEREX technique for the identification of leukaemia-associated antigensBarbara-ann Guinn, Joseph F Collin, Geng Li, et al.
Plos One|June 4, 2016
Prediction of Pathological Stage in Patients with Prostate Cancer: A Neuro-Fuzzy ModelGeorgina Cosma, Giovanni Acampora, David Brown, et al.
Cancer Immunology, Immunotherapy : CII|April 10, 2003
International conference: progress in vaccination against cancer (PIVAC) 2002, Nottingham, UKRobert C Rees, R Adrian Robins, Graham Pawelec, et al.
Advanced Healthcare Materials|November 14, 2014
Controlling the dynamics of cell transition in heterogeneous cultures using surface chemistryGraham J Hickman, Robert C Rees, David J Boocock, et al.
Current Opinion in Molecular Therapeutics|March 9, 2002
Disabled infectious single cycle-herpes simplex virus (DISC-HSV) as a vector for immunogene therapy of cancerRobert C Rees, Stephanie McArdle, Shahid Mian, et al.
Cancer Immunology, Immunotherapy : CII|March 5, 2009
Tumour antigen-targeted immunotherapy for chronic myeloid leukaemia: is it still viable?Catherine L Riley, Morgan G Mathieu, Richard E Clark, et al.
BJU International|August 20, 2011
Expression of the tumour antigen T21 is up-regulated in prostate cancer and is associated with tumour stageAmanda K Miles, Alistair Rogers, Thomas McCulloch, et al.
Cancer Immunology, Immunotherapy : CII|March 24, 2006
The role of CD4+ T cell help in cancer immunity and the formulation of novel cancer vaccinesDeepak P Assudani, Roger B V Horton, Morgan G Mathieu, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Cancer Immunology, Immunotherapy : CII|January 13, 2006
The identification of human tumour antigens: Current status and future developmentsAmanda K Miles, Balwir Matharoo-Ball, Geng Li, et al.
Methods in Molecular Medicine|May 3, 2003
Phenotypic and functional differences of dendritic cells generated under different in vitro conditionsStephanie E B McArdle, Selman A Ali, Geng Li, et al.
Journal of Immunological Methods|August 23, 2002
Optimised SEREX technique for the identification of leukaemia-associated antigensBarbara-ann Guinn, Joseph F Collin, Geng Li, et al.
Plos One|June 4, 2016
Prediction of Pathological Stage in Patients with Prostate Cancer: A Neuro-Fuzzy ModelGeorgina Cosma, Giovanni Acampora, David Brown, et al.
Cancer Immunology, Immunotherapy : CII|April 10, 2003
International conference: progress in vaccination against cancer (PIVAC) 2002, Nottingham, UKRobert C Rees, R Adrian Robins, Graham Pawelec, et al.
Advanced Healthcare Materials|November 14, 2014
Controlling the dynamics of cell transition in heterogeneous cultures using surface chemistryGraham J Hickman, Robert C Rees, David J Boocock, et al.
Current Opinion in Molecular Therapeutics|March 9, 2002
Disabled infectious single cycle-herpes simplex virus (DISC-HSV) as a vector for immunogene therapy of cancerRobert C Rees, Stephanie McArdle, Shahid Mian, et al.
Cancer Immunology, Immunotherapy : CII|March 5, 2009
Tumour antigen-targeted immunotherapy for chronic myeloid leukaemia: is it still viable?Catherine L Riley, Morgan G Mathieu, Richard E Clark, et al.
BJU International|August 20, 2011
Expression of the tumour antigen T21 is up-regulated in prostate cancer and is associated with tumour stageAmanda K Miles, Alistair Rogers, Thomas McCulloch, et al.
Cancer Immunology, Immunotherapy : CII|March 24, 2006
The role of CD4+ T cell help in cancer immunity and the formulation of novel cancer vaccinesDeepak P Assudani, Roger B V Horton, Morgan G Mathieu, et al.
Pageof 6